Europe Circulating Tumor Cell (CTC) Diagnostics Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Europe Circulating Tumor Cell (CTC) Diagnostics Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Europe Circulating Tumor Cell (CTC) Diagnostics Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Europe Circulating Tumor Cell (CTC) Diagnostics Market Regional Analysis

6.2 Europe Circulating Tumor Cell (CTC) Diagnostics Market Revenue 2019-2028 (US$ Million)

6.3 Europe Circulating Tumor Cell (CTC) Diagnostics Market Forecast Analysis

7. Europe Circulating Tumor Cell (CTC) Diagnostics Market Analysis – by Technology

7.1 CTC Detection and Enrichment Method

7.1.1 Overview
7.1.2 CTC Detection and Enrichment Method: Europe Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)

7.2 CTC Direct Detection Method

7.2.1 Overview
7.2.2 CTC Direct Detection Method: Europe Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)

7.3 CTC Analysis

7.3.1 Overview
7.3.2 CTC Analysis: Europe Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)

8. Europe Circulating Tumor Cell (CTC) Diagnostics Market Analysis – by Application

8.1 Clinical/Liquid Biopsy

8.1.1 Overview
8.1.2 Clinical/Liquid Biopsy: Europe Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.2 Research

8.2.1 Overview
8.2.2 Research: Europe Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)

9. Europe Circulating Tumor Cell (CTC) Diagnostics Market Analysis – by End-User

9.1 Hospitals and Clinics

9.1.1 Overview
9.1.2 Hospitals and Clinics: Europe Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.2 Research and Academic Institutes

9.2.1 Overview
9.2.2 Research and Academic Institutes: Europe Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.3 Diagnostic Centers

9.3.1 Overview
9.3.2 Diagnostic Centers : Europe Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)

10. Europe Circulating Tumor Cell (CTC) Diagnostics Market – Europe Analysis

10.1 Overview

10.2 Europe

10.2.1 Europe Circulating Tumor Cell (CTC) Diagnostics Market Breakdown, by Key Country, 2022 and 2028 (%)
10.2.1.1 Europe Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast Analysis – by Country
10.2.1.1 UK: Europe Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.1.1 UK: Europe Circulating Tumor Cell (CTC) Diagnostics Market Breakdown, by Technology
10.2.1.1.2 UK: Europe Circulating Tumor Cell (CTC) Diagnostics Market Breakdown, by Application
10.2.1.1.3 UK: Europe Circulating Tumor Cell (CTC) Diagnostics Market Breakdown, by End-User

10.2.1.2 Germany: Europe Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.2.1 Germany: Europe Circulating Tumor Cell (CTC) Diagnostics Market Breakdown, by Technology
10.2.1.2.2 Germany: Europe Circulating Tumor Cell (CTC) Diagnostics Market Breakdown, by Application
10.2.1.2.3 Germany: Europe Circulating Tumor Cell (CTC) Diagnostics Market Breakdown, by End-User

10.2.1.3 France: Europe Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.3.1 France: Europe Circulating Tumor Cell (CTC) Diagnostics Market Breakdown, by Technology
10.2.1.3.2 France: Europe Circulating Tumor Cell (CTC) Diagnostics Market Breakdown, by Application
10.2.1.3.3 France: Europe Circulating Tumor Cell (CTC) Diagnostics Market Breakdown, by End-User

10.2.1.4 Russia: Europe Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.4.1 Russia: Europe Circulating Tumor Cell (CTC) Diagnostics Market Breakdown, by Technology
10.2.1.4.2 Russia: Europe Circulating Tumor Cell (CTC) Diagnostics Market Breakdown, by Application
10.2.1.4.3 Russia: Europe Circulating Tumor Cell (CTC) Diagnostics Market Breakdown, by End-User

10.2.1.5 Italy: Europe Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.5.1 Italy: Europe Circulating Tumor Cell (CTC) Diagnostics Market Breakdown, by Technology
10.2.1.5.2 Italy: Europe Circulating Tumor Cell (CTC) Diagnostics Market Breakdown, by Application
10.2.1.5.3 Italy: Europe Circulating Tumor Cell (CTC) Diagnostics Market Breakdown, by End-User

10.2.1.6 Rest of Europe: Europe Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.6.1 Rest of Europe: Europe Circulating Tumor Cell (CTC) Diagnostics Market Breakdown, by Technology
10.2.1.6.2 Rest of Europe: Europe Circulating Tumor Cell (CTC) Diagnostics Market Breakdown, by Application
10.2.1.6.3 Rest of Europe: Europe Circulating Tumor Cell (CTC) Diagnostics Market Breakdown, by End-User

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview

12.2 Market Initiative

12.3 Partnerships and Collaborations

12.4 Other Developments

13. Company Profiles

13.1 Thermo Fisher Scientific Inc.

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Stemcell Technologies Inc.

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Qiagen

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Advanced Cell Diagnostics, Inc. (Bio-Techne Corporation)

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Screencell

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Ikonisys, Inc

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Fluxion Biosciences

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

14. Appendix

14.1 About Business Market Insights

14.2 List of Abbreviations

Europe Circulating Tumor Cell (CTC) Diagnostics Market

Analysis By Technology (CTC Detection and Enrichment Method, CTC Direct Detection Method, and CTC Analysis), Application (Clinical/Liquid Biopsy, and Research), and End-User (Hospitals and Clinics, Research and Academic Institutes, and Diagnostic Centers)